233 related articles for article (PubMed ID: 5576192)
1. [Responsibility for adverse drug effects].
Naess K
Tidsskr Nor Laegeforen; 1971 Mar; 91(9):673-6. PubMed ID: 5576192
[No Abstract] [Full Text] [Related]
2. [Responsibility for drug reactions].
Naess K
Nord Med; 1975 Mar; 90(3):65-6. PubMed ID: 1153254
[No Abstract] [Full Text] [Related]
3. [The doctor's responsibility and risk in the prescribing of drugs].
Aschenbrenner R
Munch Med Wochenschr; 1973 Apr; 115(17):741-6. PubMed ID: 4574431
[No Abstract] [Full Text] [Related]
4. [Possibilities and limits of drug supervision].
Homann G
Med Klin; 1970 Aug; 65(35):1518-20. PubMed ID: 5516116
[No Abstract] [Full Text] [Related]
5. [Drug effectiveness in the framework of drug legislation and health insurance law].
Töns H
Internist (Berl); 1980 Jun; 21(6):339-45. PubMed ID: 7005171
[No Abstract] [Full Text] [Related]
6. [Observance of expert testimonies by the Drug Commission in health-insurance prescriptions].
Rieger HJ
Dtsch Med Wochenschr; 1974 Oct; 99(42):2126-8. PubMed ID: 4426234
[TBL] [Abstract][Full Text] [Related]
7. Law in brief: liability for drug reactions.
Bernstein AH
Hospitals; 1976 Jan; 50(1):111-2. PubMed ID: 1245319
[No Abstract] [Full Text] [Related]
8. [Proposal from the Product Liability Committee: Drug insurance for adverse effects from July 1, 1977 to be paid by manufacturers and importers].
Lakartidningen; 1976 May; 73(19):1785-6. PubMed ID: 1271903
[No Abstract] [Full Text] [Related]
9. [Physician's responsibility for the comprehension of adverse drug reactions].
Kimbel KH
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1550-8. PubMed ID: 611878
[No Abstract] [Full Text] [Related]
10. Package inserts, adverse drug reactions, and the physician's liability.
Morrell MX
Ration Drug Ther; 1975 Aug; 9(8):1-6. PubMed ID: 1144773
[No Abstract] [Full Text] [Related]
11. [New rules in reporting adverse effects of drugs].
Böttiger LE
Lakartidningen; 1974 Dec; 71(51):5288-90. PubMed ID: 4449293
[No Abstract] [Full Text] [Related]
12. [Responsibility for drug testing and control].
Büchi J
Pharm Acta Helv; 1968 Sep; 43(9):619-27. PubMed ID: 5718866
[No Abstract] [Full Text] [Related]
13. [Report from the Public Health Administration's Committee on Side-Effects (7). Reports on side-effects under therapy with drugs and peroral contraceptive agents during the period 1 August-31 December 1968].
Ugeskr Laeger; 1969 May; 131(19):846-9. PubMed ID: 5793622
[No Abstract] [Full Text] [Related]
14. [How effective is the registration of adverse effects of drugs in Denmark?].
Hansen JM; Kampmann JP; Friedmann B
Ugeskr Laeger; 1975 Jun; 137(23):1266-8. PubMed ID: 1138470
[No Abstract] [Full Text] [Related]
15. [Pharmacologic surveillance outside the hospital: necessity and methods].
Cuena R; Honorato J; Azanza JR; Suárez JR; Rubio A
Rev Med Univ Navarra; 1987; 31(3):163-6. PubMed ID: 3507792
[No Abstract] [Full Text] [Related]
16. [Work of the committee on drug side effects].
Naes K
Tidsskr Nor Laegeforen; 1975 Aug; 95(22):1237-8. PubMed ID: 1162664
[No Abstract] [Full Text] [Related]
17. [Drug safety].
Herken H
Med Klin; 1974 Apr; 69(16):659-66. PubMed ID: 4600058
[No Abstract] [Full Text] [Related]
18. [Reports on drug side effects for the period 1973-1974].
Tidsskr Nor Laegeforen; 1975 Aug; 95(22):1243-7. PubMed ID: 1162667
[No Abstract] [Full Text] [Related]
19. The Swedish Adverse Drug Reaction Committee: an important tool for safer drug therapy.
Böttiger LE
QRB Qual Rev Bull; 1981 Feb; 7(2):14-20. PubMed ID: 6785702
[No Abstract] [Full Text] [Related]
20. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
Poser S
Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225
[No Abstract] [Full Text] [Related]
[Next] [New Search]
